# Efficacy and Safety of Paracetamol and NSAIDs for Fever and Pain Management in Children with Chronic Diseases: A Narrative Review

## TL;DR

Paracetamol and ibuprofen are similarly effective for fever and pain in children with chronic diseases but have different safety concerns depending on the child's condition.

## Contribution

This review provides practical guidance on the safe use of paracetamol and NSAIDs in children with chronic diseases based on current evidence and clinical expertise.

## Key findings

- Paracetamol and ibuprofen show similar efficacy for fever and pain in children with chronic diseases.
- Paracetamol requires caution in children with malnutrition, obesity, and neuromuscular disorders due to hepatotoxicity risks.
- NSAIDs pose higher risks for children with gastrointestinal, renal, or coagulation disorders.

## Abstract

What are the main findings?
Paracetamol and ibuprofen show comparable efficacy for fever and pain in children with chronic diseases, but differ in safety profiles.Caution is needed for the use of paracetamol in children with malnutrition, obesity and neuromuscular disorders, while NSAIDs carry higher risks of complications in patients with gastrointestinal, renal and coagulation diseases.

Paracetamol and ibuprofen show comparable efficacy for fever and pain in children with chronic diseases, but differ in safety profiles.

Caution is needed for the use of paracetamol in children with malnutrition, obesity and neuromuscular disorders, while NSAIDs carry higher risks of complications in patients with gastrointestinal, renal and coagulation diseases.

What are the implications of the main findings?
Clinical decision making should integrate comorbidities, concomitant therapies, and infection status to optimize symptom control and minimize harm.Evidence is limited for many chronic pediatric conditions and new studies are warranted.

Clinical decision making should integrate comorbidities, concomitant therapies, and infection status to optimize symptom control and minimize harm.

Evidence is limited for many chronic pediatric conditions and new studies are warranted.

Background/Objectives: Fever and pain are among the most common symptoms in pediatric infections and chronic diseases, causing significant discomfort for children and concern for caregivers. Effective management is essential to relieve distress while avoiding overtreatment or undertreatment. Paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs), particularly ibuprofen, are the primary antipyretic and analgesic agents in pediatric care, but their use in children with chronic conditions might be challenging. Methods: A narrative review and clinical expert judgment were used to synthesize current evidence on the use of paracetamol and NSAIDs (especially ibuprofen) in children with some common chronic diseases. Results: Paracetamol is often considered a first-line option in several chronic conditions. Caution is warranted in children with pre-existing malnutrition, obesity, and neuromuscular disorders as these factors might increase the risk of hepatotoxicity. NSAIDs provide additional anti-inflammatory effects and comparable analgesic efficacy but should be used cautiously in some high-risk populations due to potential gastrointestinal, renal, and bleeding complications. Their use is contraindicated in children with dehydration, renal impairment, nephrotic syndrome relapses, while careful risk-benefit assessment is required in small and vulnerable neonates. Some data also suggests NSAIDs may worsen outcomes in certain acute bacterial and viral infections. Data on chronic infections such as tuberculosis, HIV, and viral hepatitis are limited, highlighting the need for further research. Combination therapy with paracetamol and ibuprofen may enhance analgesia in postoperative settings without significantly increasing adverse events. Overall, available evidence is limited and largely observational. Conclusions: This narrative review synthesizes current evidence and clinical expertise to provide practical guidance on the rational use of paracetamol and NSAIDs in children, emphasizing individualized therapy according to comorbidities, risk factors, and clinical context, particularly in vulnerable populations. A risk-adapted, evidence-based approach ensures optimal symptom control while minimizing harm, supporting safer, more effective, and family-centered care for children with fever and pain.